 |
 |

Chlorpromazine Levels and the Outcome of Treatment in Schizophrenic Patients
Philip R. A. May, MD;
Theodore Van Putten, MD;
Donald J. Jenden, MD;
Coraleeale Yale, MS;
W. J. Dixon, PhD
Arch Gen Psychiatry. 1981;38(2):202-207.
Abstract
 |  |
Plasma and saliva levels of chlorpromazine hydrochloride were measured by gas chromatography-mass spectrometry, after a standard dosage had been administered to 48 newly admitted schizophrenic patients over 28 days. Other treatments were rigorously controlled. Saliva chlorpromazine concentrations were higher than plasma concentrations generally by about four to 50 times. Saliva and plasma chlorpromazine levels were significantly related. There was great variability in individuals between plasma and saliva peaks and values over time, in plasma/saliva ratios, and in change in plasma/saliva ratio over time. Chlorpromazine plasma and saliva levels at the end of fixed, sustained dosage treatment did not correlate with the amount of improvement as measured by ten criteria from the Brief Psychiatric Rating Scale and the Mobility, Affects Cooperation, and Communication Scale. Yet levels obtained in the 24 hours after the first dose did seem related to outcome, more strongly for saliva chlorpromazine than for plasma chlorpromazine levels. A reexamination is in order of our concepts of the relationships between levels of antipsychotic drugs in the body and treatment effect.
Author Affiliations
From the Veterans Administration Medical Center, Brentwood, Calif (Drs May, Van Putten, and Dixon); the Neuropsychiatric Institute (Drs May and Van Putten) and Departments of Pharmacology (Dr Jenden) and Biomathematics (Dr Dixon), UCLA School of Medicine; and the Health Sciences Computing Facility, UCLA (Ms Yale).
Footnotes
Accepted for publication Feb 8, 1980.
Reprint requests to Veterans Administration Medical Center, Wilshire and Sawtelle Boulevards, Los Angeles, CA 90073 (Dr May).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini et al.
Arch Gen Psychiatry 1988;45:79-91.
ABSTRACT
Haloperidol: Plasma Levels and Prolactin Response as Predictors of Clinical Improvement in Schizophrenia: Chemical v Radioreceptor Plasma Level Assays
Smith et al.
Arch Gen Psychiatry 1984;41:1044-1049.
ABSTRACT
|